Tuberculosis control in China: use of modelling to develop targets and policies
Open Access
- 15 September 2015
- journal article
- research article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 93 (11), 790-798
- https://doi.org/10.2471/blt.15.154492
Abstract
It is unclear if current programmes in China can achieve the post-2015 global targets for tuberculosis - 50% reduction, in incidence and a 75% reduction in mortality by 2025. Chinese policy-makers need to maintain the recent decline in the prevalence of tuberculosis, while revising control policies to cope with an epidemic of drug-resistant tuberculosis and the effects of ongoing health reform. Health reforms are expected to shift patients from tuberculosis dispensaries to designated hospitals. We developed a mathematical model of tuberculosis control in China to help set appropriate targets and prioritize interventions that might be implemented in the next 10 years. This model indicates that, even under the most optimistic scenario - improved treatment in tuberculosis dispensaries, introduction of a new effective regimen for the treatment of drug-susceptible tuberculosis and optimal care of cases of multidrug-resistant tuberculosis - the current global targets for tuberculosis are unlikely to be reached. However, reductions in the incidence of multidrug-resistant tuberculosis should be feasible. We conclude that a shift of patients from tuberculosis dispensaries to designated hospitals is likely to hamper efforts at tuberculosis control if cure rates in the designated hospitals cannot be maintained at a high level. Our results can inform the planning of tuberculosis control in China.This publication has 20 references indexed in Scilit:
- Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic reviewBMC Infectious Diseases, 2013
- Xpert (R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review)Published by Wiley ,2012
- Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic EvaluationPLoS Medicine, 2012
- The impact of new tuberculosis diagnostics on transmission: why context mattersBulletin of the World Health Organization, 2012
- National Survey of Drug-Resistant Tuberculosis in ChinaThe New England Journal of Medicine, 2012
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences of the United States of America, 2009
- Bayesian melding for estimating uncertainty in national HIV prevalence estimatesSexually Transmitted Infections, 2008
- Inference for Deterministic Simulation Models: The Bayesian Melding ApproachJournal of the American Statistical Association, 2000